Patent details

EP2197918 Title: COMBINATION THERAPY WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES

Basic Information

Publication number:
EP2197918
PCT Application Number:
PCT/EP/2008/006833
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087856423
PCT Publication Number:
WO/2009/030368
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES
French Title of Invention:
POLYTHÉRAPIE AVEC DES ANTICORPS ANTI-CD20 DE TYPE I ET DE TYPE II
German Title of Invention:
KOMBINATIONSTHERAPIE MIT TYP-I- UND TYP-II-ANTI-CD20-ANTIKÖRPERN
SPC Number:

Dates

Filing date:
20/08/2008
Grant date:
18/12/2013
EP Publication Date:
18/12/2013
PCT Publication Date:
12/03/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/06/2010
EP B1 Publication Date:
18/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/08/2014
Expiration date:
20/08/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/08/2008
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Name:
Roche Glycart AG
Address:
Wagistrasse 18, 8952 Schlieren-Zuerich, Switzerland (CH)

Inventor

1

Name:
UMANA Pablo
Address:
Switzerland (CH)

2

Name:
FRIESS Thomas
Address:
Germany (DE)

3

Name:
KLEIN Christian
Address:
Switzerland (CH)

Priority

Priority Number:
07017337
Priority Date:
05/09/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07K 16/28;
Filing date Document type Number of pages